BioXcel Therapeutics, Inc. Common Stock
$1.59
Volume:
316.557K ($512.38K)
Market Capitalization:
$34.77M
BioXcel Therapeutics Price Chart
BioXcel Therapeutics Price Chart
11:59 AM
1:19 PM
2:39 PM
3:59 PM
5:19 PM
6:39 PM
7:59 PM 1.64 1.62 1.61 1.60 1.59 1.58 1.56
BioXcel Therapeutics Volume Chart
BioXcel Therapeutics Volume Chart
11:59 AM 1:19 PM 2:39 PM 3:59 PM 5:19 PM 6:39 PM 7:59 PM
17.27K 14.80K 12.34K 9.87K 7.40K 4.93K 2.47K
BioXcel Therapeutics Market Segments
After Hours -0.01(-0.63%)
Open $1.60 Close $1.59 Low $1.58 Low Change -0.02 (-1.25%) High $1.62 High Change +0.02 (+1.25%) Range $0.04 Volume 5.933K Dollar Volume $9.43K
Regular Trading Hours +0.05(+3.18%)
Open $1.57 Close $1.62 Low $1.53 Low Change -0.04 (-2.55%) High $1.64 High Change +0.07 (+4.14%) Range $0.11 Volume 303.989K Dollar Volume $492.46K
Premarket -0.01(-0.63%)
Open $1.59 Close $1.58 Low $1.56 Low Change -0.03 (-1.89%) High $1.61 High Change +0.02 (+1.26%) Range $0.05 Volume 6.635K Dollar Volume $10.48K
After Hours Yesterday +0.01(+0.64%)
Open $1.56 Close $1.57 Low $1.56 Low Change 0.00 (0.00%) High $1.59 High Change +0.03 (+1.87%) Range $0.03 Volume 1.001K Dollar Volume $1.57K
Regular Trading Hours Yesterday -0.04(-2.20%)
Open $1.59 Close $1.56 Low $1.55 Low Change -0.04 (-2.52%) High $1.63 High Change +0.04 (+2.52%) Range $0.08 Volume 172.258K Dollar Volume $267.86K
Premarket Yesterday -0.02(-0.94%)
Open $1.60 Close $1.58 Low $1.58 Low Change -0.02 (-0.94%) High $1.62 High Change +0.03 (+1.57%) Range $0.04 Volume 969 Dollar Volume $1.53K
BioXcel Therapeutics Statistics
Average Volume (30 Days) 453.22K
P/E Ratio (Current) -.50
EPS (Current) -$3.12
Dividend Yield 0.00%
Free Cash Flow —
Cash Ratio 0.96
Current Ratio 1.14
Quick Ratio 1.13
Debt to Equity -1.23
Enterprise Value $107.28M
EV to EBITDA -2.14
EV to Sales 142.67
Price to Book -0.39
Price to Cash Flow —
Price to Free Cash Flow —
Price to Sales 45.66
Return on Assets -1.52%
Return on Equity 0.77%
BioXcel Therapeutics Stock Splits
There has been 1 stock split for BioXcel Therapeutics (BTAI). The reverse stock split occured on February 10, 2025 and reduced the outstanding shares at a ratio of 16:1.
Date Type Ratio February 10, 2025 Reverse 16:1